Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 345-350

  Otsuka, Eri ^a   Hirano, Kiyoko ^a   Matsushita, Shouji ^a   Inoue, Atsuto ^a   Hirose, Shigehisa ^a   Yamaguchi, Akira ^b   Hagiwara, Hiromi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

CGMP; Nitric oxide (NO): Nitric oxide (NO) donor; Osteoblast; Soluble guanylate cyclase

Indexed keywords

1 HYDROXY 2 OXO 3 (N METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; 2,2' BIS(HYDROXYNITROSOHYDRAZINO)ETHYLAMINE; 3 (2 HYDROXY 1 METHYL 2 NITROSOHYDRAZINO) N METHYL 1 PROPANAMINE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ALKALINE PHOSPHATASE; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; OSTEOCALCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; IN VITRO STUDY; MINERALIZATION; NEWBORN; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, SUCKLING; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE; NITROSO COMPOUNDS; OSTEOBLASTS; RATS; RATS, WISTAR;

EID: 0032557474     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00190-3     Document Type: Article

References (28)

1. Antosz M.E., Bellows C.G., Aubin J.E. Effects of TGF-β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated foetal rat calvaria cells. J. Cell Physiol. 140:1989;386-395.
2. Chae H.-J., Park R.-K., Chung H.-T., Kang J.-S., Kim M.-S., Choi D.-Y., Bang B.-G., Kim H.-R. Nitric oxide is a regulator of bone remodelling. J. Pharm. Pharmacol. 49:1997;897-902.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acidguanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Damoulis P.D., Hauschka P.V. Cytokines induce nitric oxide production in mouse osteoblasts. Biochem. Biophys. Res. Commun. 201:1994;924-931.
5. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
6. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17(Suppl. 3):1991;S25-S33.
7. Gudi T., Huvar I., Meinecke M., Lohmann S.M., Boss G.R., Pilz R.B. Regulation of gene expression by cGMP-dependent protein kinase: transactivation of the c-fos promoter. J. Biol. Chem. 271:1996;4597-4600.
8. Hagiwara H., Inoue A., Yamaguchi A., Yokose S., Furuya M., Tanaka S., Hirose S. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am. J. Physiol. 270:1996;C1311-C1318.
9. Hagiwara H., Hirose S., Takei Y. Natriuretic peptides and their receptors. Zool. Sci. 12:1995;141-149.
10. Harris S.E., Bonewald L.F., Harris M.A., Sabatini M., Dallas S., Feng J.Q., Ghosh-Choudhury N., Wozney J., Mundy G.R. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9:1994;855-863.
11. Helfrich M.H., Evans D.E., Grabowski P.S., Pollock J.S., Ohshima H., Ralston S.H. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J. Bone Miner. Res. 12:1997;1108-1115.
12. Hikiji H., Shin W.S., Oida S., Takato T., Koizumi T., Toyo-oka T. Direct action of nitric oxide on osteoblastic differentiation. FEBS Lett. 410:1997;238-242.
13. Holliday L.S., Dean A.D., Lin R.H., Greenwald J.E., Gluck S.L. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am. J. Physiol. 272:1997;F283-F291.
14. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1993;1472-1476.
15. Inoue A., Hiruma Y., Hirose S., Yamaguchi A., Hagiwara H. Reciprocal regulation by cyclic nucleotides of the differentiation of rat osteoblast-like cells and mineralization of nodules. Biochem. Biophys. Res. Commun. 215:1995;1104-1110.
16. Inoue A., Hiruma Y., Hirose S., Yamaguchi A., Furuya M., Tanaka S., Hagiwara H. Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 221:1996;703-707.
17. Kasten T.P., Collin-Osdoby P., Patel N., Osdoby P., Krukowski M., Misko T.P., Settle S.L., Currie M.G., Nickols G.A. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;3569-3573.
18. Kiedrowski L., Manev H., Costa E., Wroblewski J.T. Inhibition of glutamate-induced cell death by sodium nitroprusside is not mediated by nitric oxide. Neuropharmacology. 30:1991;1241-1243.
19. Lowik C.W.G.M., Nibbering P.H., van deRuit M., Papapoulos S.E. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J. Clin. Invest. 93:1994;1465-1472.
20. Lian J., Stewart C., Puchacz E., Mackowiak S., Shalhoub V., Collart D., Zambetti G., Stein G. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. USA. 86:1989;1143-1147.
21. Lowry O.H., Roberts N.R., Wu M.L., Hixon W.S., Crawford E.J. The quantitative histochemistry of brain: II. Enzyme measurements. J. Cell. Biochem. 207:1954;19-37.
22. Maclntyre I., Zaidi M., Alam A.S.M.T., Datta H.K., Moonga B.S., Lidbury P.S., Hecker M., Vane J.R. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA. 88:1991;2936-2940.
23. Moncada S., Palmer R.M.J., Hibbs J.R., Higgs A.E. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
24. Ralston S.H., Grabowski P.S. Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone. 19:1996;29-33.
25. Riancho J.A., Salas E., Zarrabeitia M.T., Olmos J.M., Amado J.A., Fernandez-Luna J.L., Gonzalez-Macias J. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J. Bone Miner. Res. 10:1995;439-446.
26. Stein G.S., Lian J.B., Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:1990;3111-3123.
27. Yamaguchi A., Kahn A.J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif. Tissue Int. 49:1991;221-225.
28. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113:1991;681-687.